Literature DB >> 25748956

Methotrexate-related primary hepatic lymphoma in a patient with rheumatoid arthritis.

Koichiro Miyagawa1, Michihiko Shibata, Hirotsugu Noguchi, Tsuguru Hayashi, Shinji Oe, Masaaki Hiura, Shintaro Abe, Masaru Harada.   

Abstract

A 56-year-old woman with rheumatoid arthritis treated with methotrexate (MTX) was admitted to our hospital due to multiple liver tumors. Contrast-enhanced computed tomography (CT) revealed multiple hypovascular masses, and 18F-fluorodeoxyglucose positron emission tomography CT showed diffuse abnormal accumulation in the liver only. We therefore made a diagnosis of MTX-related primary hepatic lymphoma (MTX-PHL) exhibiting features of diffuse large B-cell lymphoma. Although MTX has been reported to increase the risk of lymphoproliferative disorders, MTX-PHL has not been reported previously. The present case is the first case in which MTX appears to have been involved in the development of PHL.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25748956     DOI： 10.2169/internalmedicine.54.3361

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


  9 in total

1.  A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.

Authors:  Ruby Matsumoto; Kazushi Numata; Nobutaka Doba; Koji Hara; Makoto Chuma; Hiroyuki Fukuda; Akito Nozaki; Katsuaki Tanaka; Yoshimi Ishii; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2016-08-30       Impact factor: 1.314

2.  Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma.

Authors:  Ai Kawahara; Junichi Tsukada; Takahiro Yamaguchi; Takefumi Katsuragi; Takehiro Higashi
Journal:  Biomark Res       Date:  2015-05-06

3.  Hypercalcemia due to Primary Hepatic Lymphoma.

Authors:  Andrew Hsu; Michael Gagnier; Elizabeth Ryer; Mohammed Salhab; Alan G Rosmarin
Journal:  Case Rep Hematol       Date:  2016-12-25

4.  Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: A case report.

Authors:  Daisuke Takei; Tomoyuki Abe; Hironobu Amano; Naomichi Hirano; Tsuyoshi Kobayashi; Hideki Ohdan; Toshinori Kondo; Masahiro Nakahara; Toshio Noriyuki
Journal:  Int J Surg Case Rep       Date:  2016-12-21

5.  An unusual case of primary hepatic lymphoma with dramatic but unsustained response to bendamustine plus rituximab and literature review.

Authors:  Sih-Han Liao; Yin-Kai Chen; Shan-Chi Yu; Ming-Shiang Wu; Hsiu-Po Wang; Ping-Huei Tseng
Journal:  SAGE Open Med Case Rep       Date:  2017-05-26

6.  MR Imaging of a Methotrexate-associated Diffuse Large B-cell Lymphoma in the Liver that Regressed without Treatment.

Authors:  Shota Morikawa; Ayako Morita; Ritsuko Fujimitsu; Yoshifumi Kuroki; Hiroshi Urakawa; Yoshinobu Shinagawa; Daisuke Morihara; Mikiko Aoki; Kengo Yoshimitsu
Journal:  Magn Reson Med Sci       Date:  2015-12-28       Impact factor: 2.471

7.  Methotrexate-associated primary hepatic lymphoma and cranial neuropathy in a patient with rheumatoid arthritis: A case report with clinical follow-up over a 7-year period.

Authors:  Ji Eun Park; Kyung Mi Lee; Hye Young Choi; Sung Eun Ahn; Myung-Won You
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 8.  Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.

Authors:  Ayumi Ogawa; Tsuyoshi Nakagawa; Yuichi Kumaki; Tokuko Hosoya; Goshi Oda; Mio Mori; Tomoyuki Fujioka; Kazunori Kubota; Iichiro Onishi; Hiroyuki Uetake
Journal:  J Med Case Rep       Date:  2022-02-07

9.  Methotrexate-related lymphoproliferative disorders in the liver: Case presentation and mini-review.

Authors:  Takeshi Mizusawa; Kenya Kamimura; Hiroki Sato; Takeshi Suda; Hiroyuki Fukunari; Go Hasegawa; Osamu Shibata; Shinichi Morita; Akira Sakamaki; Junji Yokoyama; Yu Saito; Yoshihisa Hori; Yuduru Maruyama; Fumitoshi Yoshimine; Takahiro Hoshi; Shinichi Morita; Tsutomu Kanefuji; Masaaki Kobayashi; Shuji Terai
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.